Melanoma trials in Australia

In Australia 49 Also abroad 579

49 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Where
Wollstonecraft
Age
18 years and over
People
254 worldwide
Run by
Obsidian Therapeutics, Inc.
See details and how to joinNCT06060613
Early phase 1Taking people
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Where
Adelaide, Gosford, Kingswood, Murdoch, Southport, Wollongong
Age
18 years and over
People
30
Run by
Radiopharm Theranostics, Ltd
See details and how to joinNCT06305962
Phase 2Taking people
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Where
Adelaide, Benowa, Birtinya, North Sydney
Age
18 years and over
People
750 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00
Phase 2Taking people
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Where
Abbotsford, Leederville, Melbourne, Northcote
Age
18 years to 80 years
People
87
Run by
Psyence Australia Pty Ltd
See details and how to joinNCT07072728
Phase 1Taking people
A Study of MGC026 in Participants With Advanced Solid Tumors
Where
Auchenflower, Heidelberg, Kurralta Park
Age
18 years and over
People
394 worldwide
Run by
MacroGenics
See details and how to joinNCT06242470
Phase 1/2Taking people
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Where
Wollstonecraft
Age
18 years and over
People
220 worldwide
Run by
Strand Therapeutics Inc.
See details and how to joinNCT07751042
Phase 2Taking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Camperdown, Chermside, Clayton, Hobart, Hyde Park
Age
18 years and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
Phase 1/2Taking people
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Where
Blacktown, Mount Kuring-Gai, St Leonards, Subiaco, Woolloongabba
Age
18 years and over
People
680 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00
Phase 2Taking people
The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma
Where
Cairns, Greenslopes, Melbourne, Nedlands, Waratah, Woolloongabba
Age
18 years and over
People
48
Run by
Primmune Therapeutics, Inc.
See details and how to joinNCT07565285
Phase 1/2Taking people
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Where
Birtinya, Blacktown, Brisbane, Camperdown, Concord, Gold Coast, Nedlands, New Lambton Heights, Sydney, Waratah
Age
18 years and over
People
862 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT05914116
Phase 1/2Taking people
Intratumoral N17350 in Advanced Solid Tumors
Where
Melbourne, Newcastle, Westmead
Age
18 years and over
People
275 worldwide
Run by
Onchilles Pharma Inc
See details and how to joinNCT07339176
Phase 1/2Taking people
Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
Where
Melbourne
Age
18 years and over
People
46
Run by
Melanoma and Skin Cancer Trials Limited
See details and how to joinNCT06163820
Phase 1/2Taking people
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Where
Adelaide, Blacktown, Darlinghurst, Frankston, Heidelberg, Melbourne, Nedlands, Southport, Wollstonecraft
Age
18 years and over
People
1,438 worldwide
Run by
BioNTech SE
See details and how to joinNCT07070232 · EU 2024-517261-16-00
Phase 2Taking people
Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
Where
Adelaide, East Melbourne, Melbourne, Perth, Sydney, Waratah, Wollstonecraft, Woolloongabba
Age
18 years to 120 years
People
218 worldwide
Run by
Melanoma Institute Australia
See details and how to joinNCT03340129 · EU 2024-518545-13-00
Phase 1/2Taking people
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Where
East Melbourne
Age
18 years and over
People
120 worldwide
Run by
AstraZeneca
See details and how to joinNCT07115043
No phaseTaking people
Personalised Immunotherapy Platform
Where
Sydney
Age
18 years and over
People
1,000
Run by
Melanoma Institute Australia
See details and how to joinNCT06536257
Phase 2/3Taking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Bedford Park, Box Hill, Chermside, Frankston, Wollongong
Age
18 years and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
Phase 2Taking people
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Where
Blacktown, Nedlands, Wollstonecraft
Age
18 years and over
People
160 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06961006
Phase 3Taking people
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Where
Bedford Park, Greenslopes, Melbourne, Murdoch, Westmead
Age
18 years to 70 years
People
670 worldwide
Run by
Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00
Phase 1/2Taking people
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Where
Bedford Park, Clayton, Frankston, Heidelberg, Melbourne, Miranda, Saint Albans
Age
18 years and over
People
159 worldwide
Run by
Aulos Bioscience, Inc.
See details and how to joinNCT05267626
Phase 3Taking people
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Where
Darlinghurst, Fremantle, South Yarra, Westmead, Woolloongabba
Age
18 years and over
People
369 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06585410
Phase 1/2Taking people
SL-28 for Advanced Solid Tumours
Where
Adelaide, Gold Coast, Sydney
Age
18 years and over
People
60
Run by
Second Life Therapeutics
See details and how to joinNCT07341737
Phase 1Taking people
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Where
Heidelberg, Perth, Southport, Waratah, Wollstonecraft
Age
18 years and over
People
400 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT04913285
Phase 1/2Taking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Blacktown, Brisbane, Liverpool, Malvern, Melbourne, Nedlands
Age
18 years and over
People
1,109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
Phase 1Taking people
IDOV-Immune for Advanced Solid Tumors
Where
Melbourne, Westmead
Age
18 years and over
People
78 worldwide
Run by
ViroMissile, Inc.
See details and how to joinNCT06910657